Page 1

? Back to all press release | Save / Print as April 13th , 2021 Organigram Reports Second Quarter Fiscal 2021 Results • Launched 62 new stock - keeping units ( SKUs ) since July 2020 as part of the Company's product portfolio revitalization ; up to 31 more SKUs expected to launch by the end of Q3 2021 • SHRED was the # 1 most - searched brand on the Ontario Cannabis Store website for the last 5 consecutive months¹ and Edison was among the most - searched brands in November 2020 , January and February 2021 • On March 11 , 2021 , announced a product development collaboration with BAT and a strategic investment of - $ 221 million from a BAT subsidiary for 19.9 % equity interest in Organigram • On April 1 , 2021 , repaid all outstanding balances under the credit facility agreement for annual interest savings of $ 2.7 million² and has a current balance of $ 232 million in cash and short - term investments • On April 6 , 2021 , announced the acquisition of all the issued and outstanding shares of The Edibles and Infusions Corporation which positions the Company to earn near term revenue and a growth platform from soft chews , the largest edible category MONCTON , New Brunswick -- ( BUSINESS WIRE ) -- Organigram Holdings Inc. ( NASDAQ : OGI ) ( TSX : OGI ) , the parent company of Organigram Inc. ( together , the " Company " or " Organigram " ) , a leading licensed producer of cannabis , announced its results for the second quarter ended February 28 , 2021 ( " Q2 2021 " ) . " Although Q2 2021 results were challenged by industry dynamics , COVID - 19 and staffing limitations at our facility , we believe there are excellent prospects ahead for the industry , Organigram and our shareholders , " said Greg Engel , Chief Executive Officer of Organigram . “ Nearer term , we are currently tracking to generate higher revenue in Q3 2021 as our new product portfolio continues to gain traction and we become better staffed to fulfill demand . Our recent acquisition of The Edibles and Infusions Corporation positions us to generate revenue from the largest single category of edibles , soft chews or gummies . We also see the potential for meaningful gross margin improvement over time as we revitalize our dried flower portfolio with new Edison and Indi strains and execute on a number of opportunities including the refinement of our cultivation , post harvesting and packaging processes . Longer term , we are extremely excited about developing innovative and appealing products to consumers in collaboration with BAT . All of this is made possible and supported by strong liquidity and a balance sheet that is largely debt - free . " Select Key Financial Q2 2021 Q2 2020 % Change Metrics ( in $ 000s ) unless otherwise indicated Gross revenue 19,292 27,309 -29 % Excise taxes ( 4,649 ) ( 4,088 ) 14 % Net revenue 14,643 23,221 -37 %